Fibrinolytic activity of prostacyclin and iloprost in patients with peripheral arterial disease

This publication has 25 references indexed in Scilit:

• Prostacyclin for ischemic ulcers in peripheral arterial disease. A random assignment, placebo controlled study
  Thrombosis Research, 1985
• Hemodynamic effects of iloprost, a prostacyclin analog
  Clinical Pharmacology & Therapeutics, 1984
• Prostacyclin and the fibrinolytic system in ischemic vascular disease
  Thrombosis Research, 1983
• EPOPROSTENOL (PROSTACYCLIN) AND SEVERE ARTERIAL DISEASE
  The Lancet, 1983
• Effect of prostacyclin (PGI2) on platelets and fibrinolytic activity in patients with arteriosclerosis obliterans
  Pharmacological Research Communications, 1982
• The antiplatelet and cardiovascular actions of a new carbacyclin derivative (ZK 36 374) ? Equipotent to PGI2 in vitro
  Naunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1981
• SUCCESSFUL THERAPY OF ADVANCED ARTERIOSCLEROSIS OBLITERANS WITH PROSTACYCLIN
  The Lancet, 1979
• A lipid peroxide inhibits the enzyme in blood vessel microsomes that generates from prostaglandin endoperoxides the substance (prostaglandin X) which prevents platelet aggregation
  Prostaglandins, 1976
• Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides
  Prostaglandins, 1976
• A rapid and sensitive 125I-fibrin solid-phase fibrinolytic assay for plasmin
  Blood, 1975